Zdrowie i gospodarka · 15/05/2023

FDA Announces Final Decision on Withdrawal of MAKENA and Eight Abbreviated New Drug Applications

The FDA has made a final decision to withdraw approval of MAKENA and eight abbreviated new drug applications following a public hearing in October 2022, as announced by the Commissioner of Food and Drugs and the Chief Scientist.